May 5, 2026 Improvements in care for patients with cardiometabolic conditions, as well as decisions related to their treatment and management, increasingly depend on integrated insights drawn from diverse public and private data sources. Harnessing medical big data through AI-driven methodologies offers a promising path to meet this need. Analysis Group and Harvard T.H. Chan School of Public Health co-organized the Consortium for Obesity & Cardiometabolic Research & Evidence (CORE).